Marvin Edeas (French Institute of Health and Medical Research, Paris) on ResearchGate - Expertise: Internal Medicine (General Medicine), Oncology, Infectious Diseases
Marvin Edeas - Important Research on HIV
Six years at the Antoine Béclère Hospital made it possible for him to investigate the latency mechanisms of the HIV virus in patients with HIV, in addition to the activation factors. Significant research was carried out on the acquired immunodeficiency virus by Marvin Edeas in the 90s. In 1997, Marvin Edeas defined the factors that result in blastogenic plasma in Type 1 cases of HIV.
In the year 1998, Marvin Edeas received his doctorate on HIV infections in asymptomatic patients from Antoine Béclère Hospital. In the Internal Medicine Department at Pitié Salpêtrière, he concentrated on gastrointestinal disease. At Paris-Descartes University, Marvin Edeas focused on infectious diseases.
The SFA is committed to boosting the usage of antioxidants in health and nutrition, such as their applications in preventative and therapeutic treatments. Research on mitochondria, oxidative stress, microbiota, differentiation, inflammation, cell signalling, Nrf2 transcription factors stimulation and their implications in different pathologies are at the heart of Marvin Edeas’ research. In particular, he investigates the relationship between microbiota and mitochondria. Through the SFA, Marvin Edeas encourages exchanges and collaboration between researchers, biologists, doctors, industrialists and public health actors, etc.
Visiting Professor at the Cochin Institute - Marvin Edeas
Marvin Edeas chaired the Scientific Committee at the Targeting Microbiota and Mitochondria Congress of 2016, which brought together over 400 people. Ever since 2016, he has worked with the Paris Descartes University (Cochin Institute) as a professor (visiting). He undertakes studies in nephrology patients and studies how microbiota metabolites impact the mitochondrial activity of those patients. Marvin Edeas joined up with a team responsible for oxidative stress, inflammation and cell proliferation.
The usage of an oyster enzyme hydrolyzate within a composition that modulates oxidative stress and eliminates free radicals is what the patents Marvin Edeas filed were all about. Medicine, cosmetology and dietetics could all stand to gain from Oyster hydrolyzate. Genuine uses have been discovered for the developments made by him. Two Nrf-2 modulators separated from proteins and peptides, which can trigger the antioxidant system of defence, were discovered by Marvin Edeas.
Marvin Edeas chairs a variety of committees, including that of the Congress on Targeting Mitochondria, Microbiota, Non-invasive Markers in Various Chronic Pathologies and Glycation & Maillard Reaction. He affiliates with the Agency of Biomedicine, the Agency for the Evaluation of Research and Higher-Education, in addition to the National Center for Science in Krakow (Poland). Numerous businesses call upon Marvin Edeas’ expertise.